Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The proteasome endopeptidase complex is a large, multi-subunit protease complex essential for intracellular protein degradation. It exists primarily in the 26S and 20S forms: the 20S core is composed of four stacked rings (each with seven subunits), which form a central proteolytic chamber capable of cleaving peptide bonds with broad specificity. Protein substrates are typically recognized following polyubiquitination, unfolded, and translocated into the catalytic core for degradation into peptides. This process is fundamental for protein quality control, regulation of the cell cycle, response to cellular stress, and antigen processing for immune surveillance. Clinically, the proteasome is an important anticancer target, particularly in hematological malignancies such as multiple myeloma, where inhibitors disrupt the degradation of proapoptotic factors and key regulators, resulting in cell cycle arrest and cell death
Inhibition of proteolytic activity (especially chymotrypsin-like activity of the 20S subunit), Blocking the degradation of ubiquitinated proteins, Inducing apoptosis in target cells
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome endopeptidase complex.